Table 3.

Characteristics of primary AML patients

	Diagnose	Gender	Age (year)	FAB type	Cytogenetics	Molecular
AML#1	Refractory	Female	30	M2a	46, XX	NARAS
AML#2	De novo	Female	40	NA	46, XX	BCR/ABL BCORL1 KMT2C
AML#3	Refractory	Male	63	M2	46, XY	RUNX1
AML#4	De novo	Female	64	M2	46, XX	SH2B3
AML#5	Refractory	Female	67	M4	46, XX
AML#6	Refractory	Female	33	M5	46, XX	FLT3-ITD NPM1
AML#7	De novo	Female	33	M4	46, XX	WT1 MLL-AF9
AML#8	Refractory	Female	73	M0	46, XX	CBFB-MYH11 WT1